Creative Planning
AMAG

Creative Planning’s AMAG Pharmaceuticals AMAG Stock Holding History

Creative Planning’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-400
Closed -$7K – 4163
2017
Q2 		$7K Sell
400
-13,495
-97% -$267K ﹤0.01% 3859
2017
Q1 		$313K Buy
13,895
+12,295
+768% +$294K ﹤0.01% 1235
2016
Q4 		$56K Hold
1,600
– – ﹤0.01% 2307
2016
Q3 		$39K Buy
1,600
+1,200
+300% +$30K ﹤0.01% 2569
2016
Q2 		$10K Hold
400
– – ﹤0.01% 3272
2016
Q1 		$9K Sell
400
-11
-3% -$261 ﹤0.01% 3310
2015
Q4 		$12K Sell
411
-260
-39% -$8.4K ﹤0.01% 3213
2015
Q3 		$27K Buy
+671
New +$41.6K ﹤0.01% 2507
2015
Q2 		– Sell
-560
Closed -$31K – 3421
2015
Q1 		$31K Buy
+560
New +$26.7K ﹤0.01% 2384
2013
Q4 		– Sell
-189
Closed -$4K – 3531
2013
Q3 		$4K Buy
+189
New +$4.47K ﹤0.01% 2828

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Creative Planning's AMAG Position: Q3 2017 in Review

Creative Planning sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 400 shares — an estimated $7K sold.

Creative Planning first reported a position in AMAG in Q3 2013 and held it in 10 quarters. The position peaked at $313K in Q1 2017. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

  • Creative Planning reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 400 AMAG Pharmaceuticals shares in Q3 2017, an estimated $7K.
  • Creative Planning first reported a position in AMAG Pharmaceuticals in Q3 2013 and held it in 10 quarters.
  • Creative Planning's AMAG Pharmaceuticals position peaked at $313K in Q1 2017.
  • 187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.